Pangea Laboratory
Taikun Yamada is an experienced operations manager in the biotechnology field, currently serving at Pangea Laboratory since September 2021, where responsibilities include overseeing FDA EUA approved COVID-19 detection tests and leading a qPCR team to ensure timely results. Previously, at MyDNAge (Epimorphy LLC) from October 2019 to September 2021, Taikun managed operations for a direct-to-consumer start-up focused on epigenetic technologies and marketing the myDNAge® test. Taikun's earlier experience includes a role as a research associate at Zymo Research Corp, where cDNA synthesis and SARS-CoV-2 RNA sequencing were performed, and as a junior research specialist at the University of California, Irvine, contributing to vaccine development. Taikun holds an Associate of Science in Mathematics and Science from Palomar College, a Bachelor's degree in Pharmaceutical Sciences, and a Master of Science in Pharmacology from UC Irvine.
Pangea Laboratory
Founded in 2014, Pangea Laboratory is a CAP-accredited and CLIA-certified laboratory working to develop and offer innovative diagnostic tests and services. We are the licensed provider of Bladder CARE™, a non-invasive test that detects bladder cancer in urine by precisely measuring the methylation level of bladder cancer-specific epigenetic biomarkers.